CMTM6 and hepatocellular carcinoma: In this study, we demonstrated that the expression of CMTM6 was significantly downregulated in HCC and that patients with low CMTM6 expression had a higher risk of death and recurrence, which supports the results previously reported by Zhu et al. [31].